|
|
|
|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
| |
Fibrogen Inc 's Yearly Income from Continued Operations Growth 5 Years |
| |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
FGEN Annual Income from Cont. Operations Growth |
2024
|
2023
|
2022
|
2021
|
2019
|
| Y / Y Annual Income from Cont. Operations Change |
- |
- |
- |
- |
- |
| Annual Income from Cont. Operations (in millions $) |
$-153.10 |
$-284.23 |
$-293.65 |
$-290.02 |
$-76.97 |
|
You need to upgrade your Flash Player
|
| Companies with similar 2024 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2024 Annual Income from Cont. Operations | | Gilead Sciences Inc |  -91.45 % | $ 480.000 millions | | Roivant Sciences Ltd |  0.00 % | $ -729.919 millions | | Vertex Pharmaceuticals Inc | 0.00 % | $ -535.600 millions | | Takeda Pharmaceutical Company Limited | -55.10 % | $ 986.394 millions | | Royalty Pharma Plc | -21.76 % | $ 1,330.813 millions | | Edwards Lifesciences Corporation | -0.21 % | $ 1,396.000 millions | | Iqvia Holdings Inc |  1.10 % | $ 1,373.000 millions | | Agilent Technologies inc | 3.95 % | $ 1,289.000 millions | | Zimmer Biomet Holdings Inc | -11.71 % | $ 905.300 millions | | Organon and Co | -15.54 % | $ 864.000 millions | | United Therapeutics Corporation | 21.44 % | $ 1,195.100 millions | | Davita Inc | 30.75 % | $ 1,250.737 millions | | Quest Diagnostics Inc | 1.43 % | $ 921.000 millions | | Resmed Inc | 13.71 % | $ 1,020.951 millions | | Idexx Laboratories Inc | 4.97 % | $ 887.867 millions | | Mettler Toledo International Inc | 9.52 % | $ 863.140 millions | | Universal Health Services Inc | 61.75 % | $ 1,163.109 millions | | Incyte Corporation | -94.64 % | $ 32.615 millions | | West Pharmaceutical Services Inc | -17.03 % | $ 492.700 millions | | Dr Reddy s Laboratories Limited | 21.90 % | $ 668.000 millions | | Dexcom Inc | 6.47 % | $ 576.200 millions | | Alkermes Plc | -28.32 % | $ 372.138 millions | | Charles River Laboratories International inc | -94.79 % | $ 25.291 millions | | Encompass Health Corporation | 26.11 % | $ 599.400 millions | | Exelixis Inc | 158.49 % | $ 1,202.907 millions | | Hologic Inc | 73.03 % | $ 789.500 millions | | Align Technology inc | -5.39 % | $ 421.362 millions | | Henry Schein Inc | -8.72 % | $ 398.000 millions | | Jazz Pharmaceuticals Plc | 35.27 % | $ 560.120 millions | | Labcorp Holdings Inc | 96.58 % | $ 747.100 millions | | Teleflex Incorporated | -80.39 % | $ 70.162 millions | | Lantheus Holdings Inc | -4.29 % | $ 312.442 millions | | Avantor Inc | 121.50 % | $ 711.500 millions | | The Cooper Companies Inc | 33.33 % | $ 392.300 millions | | Medpace Holdings Inc | 43.26 % | $ 404.386 millions | | Halozyme Therapeutics Inc | 58.01 % | $ 444.091 millions | | Chemed Corporation | 10.66 % | $ 301.999 millions | | Neurocrine Biosciences Inc | 36.95 % | $ 341.300 millions | | Ensign Group Inc | 42.58 % | $ 298.458 millions | | Insulet Corporation | 102.91 % | $ 418.300 millions | | Revvity Inc | 58.10 % | $ 283.071 millions | | Biomarin Pharmaceutical Inc | 155.09 % | $ 426.859 millions | | Voyager Therapeutics Inc | 0.00 % | $ -65.002 millions | | Engene Holdings Inc | -49.54 % | $ 55.142 millions | | Steris Plc | 426.67 % | $ 553.280 millions | | Hutchmed china Limited | -62.38 % | $ 38.170 millions | | Masimo Corp | 0.00 % | $ -304.900 millions | | Siga Technologies Inc | -13.24 % | $ 59.214 millions | | Mimedx Group Inc | -38.81 % | $ 41.998 millions | | Scynexis Inc | 0.00 % | $ -21.288 millions | | Addus Homecare Corporation | 17.74 % | $ 73.598 millions |
Other Companies within Healthcare Sector and their 2024 Income from Continued Operations |
Y/Y Annual Income from Cont. Operations Growth % |
2024 Income from Continued Operations | | Eli Lilly And Company | 102.10 % | $ 10,590.000 millions | | Abbvie Inc | -12.05 % | $ 4,286.000 millions | | Regeneron Pharmaceuticals Inc | 11.61 % | $ 4,412.600 millions | | Medtronic Plc | -2.09 % | $ 3,705.000 millions | | Stryker Corp | -5.43 % | $ 2,993.000 millions | | Zoetis Inc | 6.67 % | $ 2,496.000 millions | | Pfizer Inc | 270.50 % | $ 8,051.000 millions | | Intuitive Surgical Inc | 28.62 % | $ 2,337.500 millions | | Ge Healthcare Technologies Inc | 26.70 % | $ 2,050.000 millions | | Boston Scientific Corporation | 15.95 % | $ 1,846.000 millions | | Becton Dickinson And Company | 11.44 % | $ 1,705.000 millions | | Tenet Healthcare Corp | 209.99 % | $ 4,064.000 millions | | Icon Plc | 34.30 % | $ 1,660.658 millions | | Biogen Inc | 40.57 % | $ 1,632.200 millions | | Merck and Co Inc | 4,444.56 % | $ 17,133.000 millions |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
